Join Dr. Bill Rawls as he debunks myths and reveals critical insights into the real cause of symptoms, testing, and treatment options for Lyme disease.
When: Tonight May 29, 2024
Time: 8:00 ET
Cost: FREE
Go here to register & join network
https://anh-usa.org/action-center/? Go here to contact your reps.
The House Agriculture Committee is considering amendments to the upcoming Farm Bill. We need to act fast to oppose a terrible amendment that would federally ban all ingestible hemp products with any level of THC.
This would destroy a huge percentage of the industry, including many CBD and full-spectrum hemp oil products that have many health-supporting cannabinoids along with naturally-occurring but non-intoxicating levels of THC.
You can read the text of the amendment here.
We must oppose this amendment and preserve our access to CBD and full-spectrum hemp oil products. Write to your member of Congress to oppose this amendment!
For more:
CBD is what pharmacologists call a promiscuous drug. That means it could be effective for treating a number of medical conditions. In broad strokes, CBD affects more than one process in the body – a term called polypharmacology – and so could benefit more than one medical condition.
As of early 2023, there are 202 ongoing or completed scientific trials examining the effectiveness of CBD in humans on such diverse disorders as chronic pain, substance use disorders, anxiety and arthritis.
In particular, CBD appears to be an anti-inflammatory agent and analgesic, similar to the functions of aspirin. This means it might be helpful for treating people suffering with inflammatory pain, like arthritis, or headaches and body aches.
CBD also holds potential for use in cancer therapy, although it has not been approved by the FDA for this purpose.
And this, right here, is why it simply must go. It does too many things simultaneously that interferes with Big Pharma profits and since most of our politicians are all in bed with Big Pharma, there is a concerted effort to ban it, plain and simple.
https://popularrationalism.substack.com/p/combined-early-treatment-of-dewormer?
Amazing, it only took 3 years.
Article Excerpts:
Public health, allopathic medicine, the press, and politicians infamously railed against ivermectin as a “horse dewormer.” Fauci himself single-handedly killed a good study by Henry Ford Hospital on corticosteroids and hydroxychloroquine by claiming that because we did not know if it was the corticosteroids or the hydroxychloroquine, the study was “flawed.” That study had a 1/4 reduction in mortality in hospitalized patients.
Now, a study from Thailand has been published that has found that early treatment of dewormer combined with antihistamine, expectorant, and SSRI shows major clinical efficacy against serious illness from COVID-19.
The study investigates a combined early treatment regimen of a dewormer, an antihistamine, an expectorant, and an SSRI, demonstrating significant clinical efficacy in preventing serious illness from COVID-19.This approach challenges the earlier narratives and suggests a potential shift in the treatment paradigm for COVID-19, emphasizing the benefits of combination therapy that simultaneously targets multiple aspects of the disease. (See link for article)
Dr. Been Medical Lectures
_______________
**Comment**
One would think this would shift the treatment paradigm, but nope. Not gonna happen.
_______________
https://www.theepochtimes.com/health/doctor-fined-for-prescribing-ivermectin-against-covid-19-post
A doctor in Washington state has been fined for prescribing ivermectin against COVID-19. He must also take continuing education classes, according to newly filed documents.
Dr. Wei-Hsung Lin must pay $5,000, according to an order signed by the Washington Medical Commission on May 2.
Ivermectin is approved by the U.S. Food and Drug Administration for treating several conditions, including parasitic worms. Prescribing medicine for unapproved usage is common in the United States, but administration officials have warned against prescribing and using ivermectin as a COVID-19 treatment. Regulators have pointed to a database of clinical trials, some of which found ivermectin did not confer a benefit against COVID-19 and some of which found ivermectin was beneficial against the illness. (See link for article)
_______________
**Comment**
All of this over 12 mg of ivermectin for FIVE DAYS! A drug on the WHO list of essential medicine which is handed out like candy in Africa without a prescription!
Of course, this doctor was attacked for not discussing alternative treatments, for not using the government approved treatment of remdesivir, and for not discussing the COVID gene therapy injections which have caused more reports of adverse reactions and death than any other vaccine in the history of VAERS.
Oh – besides paying a fine and needing continuing education, the doctor must write two papers of at least 1,000 words describing what he learned. The commission is also going to make annual compliance visits including a random selection of records, and the doctor must appear within a year and on an annual basis as part of compliance oversight.
I truly hope he sues them. The madness must end.
For more:
https://covid19criticalcare.com/ivermectin/
https://theintercept.com/2022/11/01/biosafety-avian-flu/
Mara Hvistendahl
11/1/2022
Article Summary & other tidbits (See link for article)
“Someone finally convinced me to do something really, really stupid,” virologist Ron Fouchier.
“We should be brave enough to say that some experiments should not be done.” ~ Simon Wain-Hobson, virologist at the Pasteur Institute in Paris
(See link for article)
________________
For more:
_______________
https://worldcouncilforhealth.substack.com/p/concerned-about-bird-flu?
Rumours of a deadly bird flu pandemic, hot on the heels of Covid-19, remind us of the disastrous results of implementing novel GMO gene products in the guise of vaccines without adequate testing.
You’ve got a dangerous vaccine for a non-threatening disease … It’s supposedly for a life-threatening illness. Of course, conjunctivitis is not life-threatening! The whole purpose of the bird flu scare is to make you think that pandemics are always lurking, they’re coming for you all the time, and you need [the health bureaucracy] to save you. ~ Dr Meryl Nass, Internist and Epidemiologist
Written by WCH Health & Science Committee lead Christof Plothe DO.
The United States Centers for Disease Control and Prevention (CDC) reports that since January 2022, the largest outbreak of avian influenza (bird flu) in recorded history has occurred worldwide (CDC, 2024). By 7 May 2024, what has been identified as a subtype of influenza, referred to as H5N1, had apparently been detected in over 9,000 wild birds and affected more than 90 million poultry in the United States alone. Bird flu outbreaks have affected regions such as Asia, Africa, Europe, the Pacific, and the Near East (CDC, 2024), wreaking havoc on the poultry industry and impacting farmers’ livelihoods and international trade.
In 2022, an independent journalist reported that former CDC Director Robert Redfield had predicted that bird flu would jump to humans and prove highly lethal, triggering a ‘Great Pandemic’, which would make Covid-19 seem like a mere warm-up (Westbrook 2022). In 2005, then-President George Bush spent over $7 billion on preparations for bird flu, warning that it could kill more than two million Americans (Bush, 2005). Despite this, naturally occurring avian influenza (H5N1) has never posed a threat to humans.
The CDC maintains that H5N1 poses a low risk to humans and that there is currently no known mechanism for human-to-human transmission. According to the World Health Organization (WHO), bird flu has been responsible for only 463 deaths worldwide over the past 20 years. They do not mention if the deceased died from bird flu or with it. (See link for article & at home treatments)
______________
**Comment**
The article points out that a PCR test cannot detect the identity of the virus nor can it detect its variants or sub-varients, so we are at the mercy, once again, of a ‘casedemic’ caused by a fraudulent test which is being manipulated for a predetermined outcome: high cases to push a fear narrative to get a lucrative injection.
May Awareness LDA Guest Blogger
Dr. Sarah Maxwell, Ph.D., Associate Professor, Public Health and Public Policy, University of Texas at Dallas. Dr. Maxwell is an expert on tick-borne disease surveillance and the use of triangulation and thematic mapping to assess tick-borne disease risk, particularly in perceived non-endemic areas and among vulnerable populations. Her recent work includes a grant from the Rita & Alex Hillman Foundation, titled Nursing in the Fields: Vector-borne Illness Prevention and Detection among Migrant and Seasonal Farmworkers. She has numerous publications on tick-borne diseases in high-impact journals. Dr. Maxwell served as a Fellow and continues her role as Faculty Affiliate at Boston University School of Medicine, Laboratory for Human Neurobiology. She is also a Research Affiliate, Center for Science, Technology, and Innovation Policy, George Mason University and founding member of Integrate, Communicate, Inform (ICI)-Vector-borne Disease Working Group.
by Dr. Sarah Maxwell, Ph.D.*
Navigating tick-borne diseases (TBDs) in the United States is analogous to traversing a labyrinth, filled with obscure pathways and blind alleys. These complex passageways found throughout state public health websites fail to provide researchers, public health officials, and medical practitioners with a quick reference to assess locally-acquired disease risk. Additionally, the Centers for Disease Control and Prevention generally do not provide county-level data on tick-borne diseases in the U.S., other than Lyme disease.[1] State public health departments offer limited TBD data, while the presentation of data is typically unhelpful at best. State reporting skips years; is inconsistently presented; or is presented in formats that make it very difficult to build a dataset, even for just one state.
For states with emerging tick-borne diseases, large states with varying eco-systems, and counties outside of the Northeastern U.S., TBDs other than Lyme disease are largely ignored. At the state level, data are often located in various formats (e.g., PDF or maps) and are inconsistently presented, particularly across years and among groups (e.g., age, gender). Knowledge of county-level disease presence is key to improved testing and diagnosis. A national data guidebook that documents all county-level TBD data is needed to assist medical practitioners in determining disease risk and travel-acquired TBDs, and to provide data access to TBD researchers so desperately need.
I therefore, reached out to the Lyme Disease Association, Inc. (LDA) with the goal to create a one-stop, quick-reference online, easy-access data guidebook. The overarching goal of this grant-funded initiative is to create a national, county-level guidebook on all tickborne diseases. The Data Guidebook will contain links to all state public health department pages related to TBDs, with a comprehensive summary of all available data. As I have begun this daunting task, however, I have also been downloading all PDFs, maps, written reports, and anything I can locate that will assist researchers to improve tick-borne disease surveillance and public health communication. These reports provide historical and fixed information so that links and changes to state public health department websites do not negatively affect the main goal, i.e., to secure TBD, county-level data in the United States over as many years as possible.
The products of this LDA-funded grant will allow researchers, epidemiologists, summer camps, schools, medical practitioners, and anyone requiring local information to obtain official data via a quick-reference manual. Researchers can quickly assess, for example, if a state offers downloadable data; if county-level data are available, and in what format; and what those data offer (see detailed description below).
a) By March, 2024: A complete directory of state TBD state public health links and information will be entered into an excel file. Note: many states have data that are only publicly available through very detailed search criteria and may not appear on the main public health websites, underscoring the importance of a one-stop source for TBD data.
b) By December, 2024: complete an analysis by state that is ready for preparation into a professional report. Examples of full report information include the following descriptive information for each state, allowing researchers and others to effectively locate and analyze TBD data:
c) By March 15th, 2025: a professional, 50-page report is prepared with one page per state. Information will be presented for quick reference by any researcher or end user, allowing open access, once and for all, to TBD county-level data in the U.S.
d) By December, 2025: publish a research note in a peer-reviewed journal outlining the report and presenting an overview and analysis of TBD public health data in the United States. This peer-reviewed research note will describe the state-of-the-states’ TBD data availability, presented in both written and summary form, similar to a health dashboard.
To fully comprehend the daunting task of mismatched data facing tick-borne disease researchers, visual illustrations are necessary. The grant launched in January, 2024, and as I now assemble the County-Level Tick-Borne Disease Data Guidebook, I can attest that it is worse than I first anticipated. States may or may not provide county-level data. If they do, it is often located in a PDF and, within that PDF, data may or may not be organized. In fact, many states present data in written paragraph form, rather than data that can be cut and pasted, and data across the board cannot be easily downloaded or converted to Excel. Additionally, within these PDFs are multiple other reportable/communicable diseases. A researcher might spend a full day pulling data from multiple links, PDFs, past reports, or even in Word documents, and most of these data are not necessarily located on one easy-to-locate website. Tick-borne diseases must be sorted out from other reportable diseases in the process. Historical data reports, if ever collected in the first place, often require significant sleuthing, digging, and searching.
Let’s face it, the United States tick-borne disease data situation is so inconsistent and complex, ChatGTP cannot even fix the problem. The complexities are shown below with examples of reports from selected states.
The Tick-Borne Disease Data Guidebook provides a summary for each state. The Excel file screenshot below highlights available data in Arkansas, one of the few states I have reviewed thus far that offers downloadable or cut-and-paste raw data that includes emerging TBDs. Good job, Arkansas! But, my request to you, Arkansas Department of Public Health, can you please start posting county-level data? With so many summer camps in Arkansas, along with countless state and national parks, historical sites, campers, backpackers, and hikers…along with notably high (and increasing) cases of diseases such as Tularemia and Rickettsiosis, Spotted Fever (RMSF), those who are unaware or are visitors to the state, may find themselves with flu-like symptoms and no explanation from their medical provider.
(Low resolution sample)
Will this grant fully solve the data problem? Sadly, no, but the Lyme Disease Association, Inc. has just funded the platform on which our collective work can now change the entire field of tick-borne disease research. We must continue to address the lack of public health information, and particularly, communication. What comes next is simple: The data will be held in separate files for each state, along with the Data Guidebook. The LDA will offer all collected information, along with the Data Guidebook entries online for anyone to access. From there, we, collectively, must develop a dashboard of all known TBDs at the county and state-levels across the United States. I am committed to this project, and the next step will be accomplished. Do you have ideas? Are you an institutional prospective partner? Feel free to reach out: sarah.maxwell@utdallas.edu Let’s support the LDA and the University of Texas at Dallas in taking that next step so that disease surveillance becomes easy and accessible, and let’s work together so that patients can be diagnosed quickly and properly with local data.
[1] The CDC offers one county-level data set for selected tick-borne diseases from 2016-2019 https://www.cdc.gov/ticks/resources/Reported-Tickborne-Disease-Cases-by-County-of-Residence_2016-2019.xlsx
*Author Note: The opinions expressed in this Blog are personal opinions of author Dr. Sarah Maxwell only and do not necessarily reflect those of any other entity.
